Sofinnova Partners and Fondazione Telethon present this new joint initiative aimed at funding and/or creating Italian biotech start-ups in the field of rare and/or genetic diseases with an investment of up to 1,5M€.

Sofinnova Telethon Fund is the largest Italian investment fund dedicated to biotech, it was born in 2018 from the collaboration between the Telethon Foundation and Sofinnova Partners.

Thanks to Sofinnova Telethon Fund Venture Contest, Fondazione Telethon makes available its expertise to select excellet research projects focused on development of a therapeutic product and / or a technological approach. Sofinnova Partners, on the other hand, makes available its management and industrial skills necessary to support the development of start-ups.

The call is dedicated to researchers belonging to an Italian public or private research Institutions and / or Italian start-ups.

This call will open to the scientific community by the second half of February 2021.

Four weeks after opening, it will be necessary to submit the title of the project, a brief description of the proposed therapeutic product and a list of the diseases covered by the proposal. The call will close eight weeks after opening.

Find out more https://www.telethon.it/en/what-we-do/research/research-calls/sofinnova-telethon-fund-venture-contest.